Literature DB >> 3534819

Pharmacologic treatments of cocaine abuse.

F Gawin, H Kleber.   

Abstract

Because current studies have small sample sizes and limited controls, firm conclusions or treatment recommendations cannot be made at present, but pharmacologic approaches probably have a place in the treatment of cocaine abuse. Pharmacologic treatments of cocaine abusers may relate to underlying psychiatric diagnoses. Cocaine abusers with adult attention deficit disorder appear to respond well to methylphenidate, but other cocaine abusers have increased cocaine craving when getting this medication. Cyclothymic cocaine abusers appear to respond to lithium with reduced cocaine use. Depressed cocaine abusers, who may constitute about 30 per cent of abusers, have decreased cocaine craving and increased abstinence when treated with desipramine. Other cocaine abusers without underlying psychiatric disorders may also respond well to desipramine if they fail to reduce their cocaine use during psychotherapy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3534819

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  13 in total

1.  β-endorphin via the delta opioid receptor is a major factor in the incubation of cocaine craving.

Authors:  Yahav Dikshtein; Royi Barnea; Noam Kronfeld; Elad Lax; Ilana Roth-Deri; Alexander Friedman; Iris Gispan; Einat Elharrar; Sarit Levy; Moshe Ben-Tzion; Gal Yadid
Journal:  Neuropsychopharmacology       Date:  2013-06-26       Impact factor: 7.853

Review 2.  From bench to bedside: mGluR2 positive allosteric modulators as medications to treat substance use disorders.

Authors:  Jane B Acri; Alan J Cross; Phil Skolnick
Journal:  Psychopharmacology (Berl)       Date:  2016-12-20       Impact factor: 4.530

Review 3.  Cocaine psychosis.

Authors:  F M Baker
Journal:  J Natl Med Assoc       Date:  1989-09       Impact factor: 1.798

Review 4.  Recent updates on incubation of drug craving: a mini-review.

Authors:  Xuan Li; Daniele Caprioli; Nathan J Marchant
Journal:  Addict Biol       Date:  2014-12-01       Impact factor: 4.280

5.  Biological markers of the effects of intravenous methylphenidate on improving inhibitory control in cocaine-dependent patients.

Authors:  Chiang-Shan R Li; Peter T Morgan; David Matuskey; Osama Abdelghany; Xi Luo; Jeremy L K Chang; Bruce J Rounsaville; Yu-shin Ding; Robert T Malison
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-26       Impact factor: 11.205

6.  Pharmacogenetic randomized trial for cocaine abuse: disulfiram and α1A-adrenoceptor gene variation.

Authors:  D Shorter; D A Nielsen; W Huang; M J Harding; S C Hamon; T R Kosten
Journal:  Eur Neuropsychopharmacol       Date:  2013-07-10       Impact factor: 4.600

Review 7.  Neurochemistry underlying relapse to opiate seeking behaviour.

Authors:  Robyn M Brown; Andrew J Lawrence
Journal:  Neurochem Res       Date:  2009-05-06       Impact factor: 3.996

8.  Effects of Kappa opioid receptor blockade by LY2444296 HCl, a selective short-acting antagonist, during chronic extended access cocaine self-administration and re-exposure in rat.

Authors:  Marta Valenza; Kyle A Windisch; Eduardo R Butelman; Brian Reed; Mary Jeanne Kreek
Journal:  Psychopharmacology (Berl)       Date:  2020-01-08       Impact factor: 4.530

9.  Dysregulated mTORC1-Dependent Translational Control: From Brain Disorders to Psychoactive Drugs.

Authors:  Emanuela Santini; Eric Klann
Journal:  Front Behav Neurosci       Date:  2011-11-08       Impact factor: 3.558

10.  Novel research translates to clinical cases of schizophrenic and cocaine psychosis.

Authors:  João V Nunes; Patricia A Broderick
Journal:  Neuropsychiatr Dis Treat       Date:  2007-08       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.